Franck Rahaghi is a Respiratory physician. OpenAlex indexes 103 publications with 1,316 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2950 Cleveland Clinic Blvd
Weston, FL 333313609
Telephone
954-659-5000Registry record last updated 3 Mar 2008.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Actelion Pharmaceuticals US, Inc.Program year20252 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Actelion Pharmaceuticals US, Inc.Program year202442 payments$33,544openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
43.8%Prostacycline Vasodilator19.7%Orenitram Er84%Tyvaso Dpi16%Part D<11 patientsProstacyclin Receptor Agonist15.1%Uptravi100%Part D≥11 patients+ 1 more class in this area
Cardiovascular
23.1%Endothelin Receptor Antagonist15.7%Opsumit81%Ambrisentan19%Part D<11 patientsSoluble Guanylate Cyclase Stimulator4.1%Adempas100%Part D<11 patients+ 2 more classes in this area
Respiratory
19.7%Corticosteroid11.3%Trelegy Ellipta81%Breo Ellipta19%Part D<11 patientsbeta2-Adrenergic Agonist4.4%Albuterol Sulfate Hfa100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients
The Lancet Respiratory Medicine
2025 - International Society for Heart and Lung Transplantation Consensus Statement on the Referral and Selection of Pediatric Lung Transplant Candidates
The Journal of Heart and Lung Transplantation
2025 - A Perspective on Referral and Selection for Pediatric Lung Transplantation
The Journal of Heart and Lung Transplantation
2025 - Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
The Lancet Respiratory Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”